A Class in Session: Understanding Current and Future Therapeutic Advances Across B-Cell Lymphomas

Download All
In this comprehensive online program, experts discuss how to select optimal therapies for patients with B-cell lymphomas. Get up to date with expert commentaries, an on-demand webcast and slides from a dynamic CCO symposium at ASH 2021, downloadable resources on 10 key agent classes, and an audio podcast.

Resources

Download this online resource developed to serve as a helpful guide for healthcare professionals on BCL-2 targeted therapies in B-cell lymphoma.

Released: December 10, 2021

Download this online resource developed to serve as a helpful guide for healthcare professionals on PI3K inhibitors in B-cell lymphoma.

Released: December 13, 2021

Download this online resource developed to serve as a helpful guide for healthcare professionals on CAR T-cell therapies in B-cell lymphoma.

Released: December 10, 2021

Download this online resource developed to serve as a helpful guide for healthcare professionals on epigenetic therapies in B-cell lymphoma.

Released: December 13, 2021

Download this online resource developed for healthcare professionals with a helpful guide for antibody-based therapies in B-cell lymphoma.

Released: December 17, 2021

Download this online resource developed to serve as a helpful guide for healthcare professionals on bispecific antibodies in B-cell lymphomas.

Released: December 27, 2021

Download this online resource developed to serve as a helpful guide for healthcare professionals on BTK inhibitors in B-cell lymphoma.

Released: January 4, 2022

Download this online resource developed to serve as a helpful guide for healthcare professionals on immunomodulatory agents and immune checkpoint inhibitors in B-cell lymphomas.

Released: December 27, 2021

Download this online resource developed to serve as a helpful guide for healthcare professionals on XPO1 and nuclear export inhibitors in B-cell lymphomas.

Released: December 28, 2021

Download this online resource developed to serve as a helpful guide for healthcare professionals on antibody–drug conjugates in B-cell lymphomas.

Released: December 29, 2021
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Atara Biotherapeutics, Inc.
Bayer HealthCare Pharmaceuticals Inc.
BeiGene, Ltd.
Epizyme
Genentech, a member of the Roche Group
Genmab US, Inc.
Incyte Corporation
Karyopharm Therapeutics
Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings